Skip to main content
. Author manuscript; available in PMC: 2023 May 23.
Published in final edited form as: Int J Pharm. 2020 Nov 27;593:120119. doi: 10.1016/j.ijpharm.2020.120119

Table 1.

Characterization of the developed SNPs-based formulations. Zeta-potential was determined for SNPs formulations diluted 10 X in 10 mM NaCl. Zeta potential is given as the mean ± SEM (n =3).

SNPs SNPs Conc. [mg/mL] MA MA Conc. (mM) OVA Conc. [μg/mL] Particle diameter ± SD (nm) Total surface area (nm2) pH zeta potential ± SD (mV)
Bare SNPs 20.0 --- --- --- --- --- 5.5 − 58 ± 4
Bare M-SNPs 20.0 --- --- --- --- --- 5.5 − 48 ± 9
A-SNPs 20.0 --- --- --- 246 ± 11 2.7 × 1017 5.4 52 ± 3
M-A-SNPs 20.0 --- --- — 362 ± 29 1.7 × 1017 5.3 46 ± 5
A-SNPs 20.0 UM1024 0.2 --- --- --- 5.3 58 ± 4
A-SNPs 20.0 UM1128 0.2 --- --- --- 5.5 55 ± 4
A-SNPs 20.0 UM1024 0.2 20 --- --- 5.3 32 ± 3
A-SNPs 20.0 UM1128 0.2 20 --- --- 5.3 33 ± 4